Patrick J. Cimino, Ph.D.
Affiliations: | University of Washington, Seattle, Seattle, WA |
Google:
"Patrick Cimino"Mean distance: 19.27 (cluster 28)
Parents
Sign in to add mentor| Thomas J. Montine | grad student | 2009 | University of Washington | |
| (DOCK2 is an EP2-dependent regulator of microglial response present in normal and Alzheimer's disease brain.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Cimino PJ, Ketchum C, Turakulov R, et al. (2022) Expanded analysis of high-grade astrocytoma with piloid features identifies an epigenetically and clinically distinct subtype associated with neurofibromatosis type 1. Acta Neuropathologica |
| Szulzewsky F, Arora S, Hoellerbauer P, et al. (2020) Comparison of tumor-associated YAP1 fusions identifies a recurrent set of functions critical for oncogenesis. Genes & Development |
| Chen Z, Herting CJ, Ross JL, et al. (2020) Genetic driver mutations introduced in identical cell-of-origin in murine glioblastoma reveal distinct immune landscapes but similar response to checkpoint blockade. Glia |
| Alexander J, LaPlant QC, Pattwell SS, et al. (2020) Multimodal single-cell analysis reveals distinct radioresistant stem-like and progenitor cell populations in murine glioma. Glia |
| Szulzewsky F, Cimino PJ. (2020) Fusing the Genetic Landscape of Infantile High-Grade Gliomas. Cancer Discovery. 10: 904-906 |
| Pattwell SS, Arora S, Cimino PJ, et al. (2020) A kinase-deficient NTRK2 splice variant predominates in glioma and amplifies several oncogenic signaling pathways. Nature Communications. 11: 2977 |
| Pattwell SS, Konnick EQ, Liu YJ, et al. (2020) () Alterations in Low-Grade Gliomas: Report of a Novel Gene Fusion Partner in a Pilocytic Astrocytoma and Review of the Literature. Case Reports in Pathology. 2020: 5903863 |
| Eastman BM, Cimino PJ, McGranahan T, et al. (2020) Craniospinal irradiation in patients diagnosed with glioblastoma with primitive neuronal component prevents distant intracranial and leptomeningeal recurrences. Journal of Clinical Oncology. 38: e14540-e14540 |
| Kaffes I, Szulzewsky F, Chen Z, et al. (2019) Human Mesenchymal glioblastomas are characterized by an increased immune cell presence compared to Proneural and Classical tumors. Oncoimmunology. 8: e1655360 |
| Parada CA, Osbun JW, Busald T, et al. (2019) Phosphoproteomic and Kinomic Signature of Clinically Aggressive Grade I (1.5) Meningiomas Reveals Rb1 signaling as a Novel Mediator and Biomarker. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research |